University of Ioannina
Διερεύνηση επαγωγής του ανοσολογικού κυτταρικού θανάτου (ICD) από στοχευτικά και κυτταροτοξικά αντινεοπλασματικά φάρμακα σε συμπαγείς όγκους και in vivo μελέτη βιοδεικτών ICD σε ασθενείς
Abstract
dc:descriptionColorectal cancer is one of the most frequently encountered malignancies. Both cytotoxic and targeted antineoplastic treatments, have prolonged survival and ameliorated quality of life of affected patients. Agents very often employed against colorectal cancer, such as oxaliplatin and cetuximab, may also enhance host’s immunogenicity, by inducing Immunogenic Cell Death (ICD). ICD induction in patients has not yet been systematically studied. We aimed to investigate changes in local immune response, during antineoplastic treatment, and research for relative biomarkers, in colorectal cancer patients. A retrospective study of 20 colorectal cancer patient cases, with available tissue material from 1 to 2 tumor sites was performed. Tissue material was evaluated for density of Tumor Infiltrating Lymphocytes (TILs), as well as CD3, CD8, CD4 and FOXP3 positive subpopulations, both in primary and metastatic tumor sites. A significant association was shown between increased stromal and total CD3 positive TILs density and male sex, as well as between better differentiated neoplasms and stromal/total CD8 positive TILs concentration, regarding the primary tumor site. 95% of patients received oxaliplatin as perioperative and/or systematic treatment, while 15% and 45% of patients received neoadjuvant/adjuvant and systematic treatment with cetuximab, respectively. For patients with available tissue material from both primary and secondary tumor sites, we observed an increased concentration of stromal and total CD8, CD3, CD4 and FOXP3 positive TILs, in the secondary cancer sites, compared to the primary site. Median overall survival was 63 months. No association between TILs subpopulations in the primary or secondary tumor site and patient overall or progression free survival was found. Immune system activation may increase during disease course, and in parallel with the antineoplastic treatment administration, although increased in local immune infiltration did not seem to affect patient survival. Immune enhancing effect of broadly used cytotoxic and targeted agents, may serve a background for immunotherapy administration, as salvage or maintenance treatment, especially in patients whose tumors do not express established immunotherapy biomarkers.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Gazouli, Ioanna
- Γαζούλη, Ιωάννα
Subjects
dc:subject × 17- Καρκίνος παχέος εντέρου
- Ανοσοθεραπεία
- Λεμφοκύτταρα ανθρώπου
- Ανοσογονικότητα
- Κυτταρικός θάνατος
- Προγραμματισμένος κυτταρικός θάνατος
- Colorectal cancer
- Cancer immunotherapy
- Ιmmunogenicity
- Lymphocytes in colorectal cancer
- TIL (Tumor Infiltrating Lymphocytes)
- Άλλες Ιατρικές Επιστήμες
- Ιατρική και Επιστήμες Υγείας
- Ιατρική έρευνα και Πειραματική ιατρική
- Other Medical Sciences
- Medical and Health Sciences
- Research and Experimental medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59006